99 related articles for article (PubMed ID: 17010315)
21. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo.
Watanabe N; Takaoka M; Sakurama K; Tomono Y; Hatakeyama S; Ohmori O; Motoki T; Shirakawa Y; Yamatsuji T; Haisa M; Matsuoka J; Beer DG; Nagatsuka H; Tanaka N; Naomoto Y
Clin Cancer Res; 2008 Jul; 14(14):4631-9. PubMed ID: 18628478
[TBL] [Abstract][Full Text] [Related]
22. [The role of FAK expression inhibition by RNA interference on liver cancer cells].
Yuan Z; Zheng Q; Huang XY; Fan J
Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(19):1350-3. PubMed ID: 18241574
[TBL] [Abstract][Full Text] [Related]
23. Thrombospondin-1-induced migration is functionally dependent upon focal adhesion kinase.
Wang XJ; Maier K; Fuse S; Willis AI; Olson E; Nesselroth S; Sumpio BE; Gahtan V
Vasc Endovascular Surg; 2008; 42(3):256-62. PubMed ID: 18319354
[TBL] [Abstract][Full Text] [Related]
24. Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes.
Laczko R; Szauter KM; Jansen MK; Hollosi P; Muranyi M; Molnar J; Fong KS; Hinek A; Csiszar K
Neuropathol Appl Neurobiol; 2007 Dec; 33(6):631-43. PubMed ID: 17931358
[TBL] [Abstract][Full Text] [Related]
25. Focal adhesion kinase (FAK) expression and activation during lens development.
Kokkinos MI; Brown HJ; de Iongh RU
Mol Vis; 2007 Mar; 13():418-30. PubMed ID: 17417603
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells.
Hiscox S; Barnfather P; Hayes E; Bramble P; Christensen J; Nicholson RI; Barrett-Lee P
Breast Cancer Res Treat; 2011 Feb; 125(3):659-69. PubMed ID: 20354780
[TBL] [Abstract][Full Text] [Related]
27. Disruption of FRNK expression by gene targeting of the intronic promoter within the focal adhesion kinase gene.
Hayasaka H; Martin KH; Hershey ED; Parsons JT
J Cell Biochem; 2007 Nov; 102(4):947-54. PubMed ID: 17440961
[TBL] [Abstract][Full Text] [Related]
28. Wilms' tumor 1 protein and focal adhesion kinase mediate keratinocyte growth factor signaling in breast cancer cells.
Zang XP; Pento JT; Tari AM
Anticancer Res; 2008; 28(1A):133-7. PubMed ID: 18383836
[TBL] [Abstract][Full Text] [Related]
29. FAK phosphorylation at Ser-843 inhibits Tyr-397 phosphorylation, cell spreading and migration.
Jacamo R; Jiang X; Lunn JA; Rozengurt E
J Cell Physiol; 2007 Feb; 210(2):436-44. PubMed ID: 17096371
[TBL] [Abstract][Full Text] [Related]
30. The tyrosine phosphatase HD-PTP: A novel player in endothelial migration.
Castiglioni S; Maier JA; Mariotti M
Biochem Biophys Res Commun; 2007 Dec; 364(3):534-9. PubMed ID: 17959146
[TBL] [Abstract][Full Text] [Related]
31. Tissue factor pathway inhibitor (TFPI) interferes with endothelial cell migration by inhibition of both the Erk pathway and focal adhesion proteins.
Provençal M; Michaud M; Beaulieu E; Ratel D; Rivard GE; Gingras D; Béliveau R
Thromb Haemost; 2008 Mar; 99(3):576-85. PubMed ID: 18327407
[TBL] [Abstract][Full Text] [Related]
32. Signal transduction by focal adhesion kinase in cancer.
Zhao J; Guan JL
Cancer Metastasis Rev; 2009 Jun; 28(1-2):35-49. PubMed ID: 19169797
[TBL] [Abstract][Full Text] [Related]
33. Focal adhesion kinase: important to prostaglandin E2-mediated adhesion, migration and invasion in hepatocellular carcinoma cells.
Bai XM; Zhang W; Liu NB; Jiang H; Lou KX; Peng T; Ma J; Zhang L; Zhang H; Leng J
Oncol Rep; 2009 Jan; 21(1):129-36. PubMed ID: 19082453
[TBL] [Abstract][Full Text] [Related]
34. Focal adhesion kinase (FAK) immunocytochemical expression in breast ductal invasive carcinoma (DIC): correlation with clinicopathological parameters and tumor proliferative capacity.
Theocharis SE; Klijanienko JT; Padoy E; Athanassiou S; Sastre-Garau XX
Med Sci Monit; 2009 Aug; 15(8):BR221-6. PubMed ID: 19644410
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549.
Liu G; Meng X; Jin Y; Bai J; Zhao Y; Cui X; Chen F; Fu S
Cell Biol Int; 2008 Jun; 32(6):663-70. PubMed ID: 18343694
[TBL] [Abstract][Full Text] [Related]
36. FAK silencing inhibits leukemogenesis in BCR/ABL-transformed hematopoietic cells.
Le Y; Xu L; Lu J; Fang J; Nardi V; Chai L; Silberstein LE
Am J Hematol; 2009 May; 84(5):273-8. PubMed ID: 19358301
[TBL] [Abstract][Full Text] [Related]
37. High affinity interaction of integrin alpha4beta1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers.
Klemke M; Weschenfelder T; Konstandin MH; Samstag Y
J Cell Physiol; 2007 Aug; 212(2):368-74. PubMed ID: 17352405
[TBL] [Abstract][Full Text] [Related]
38. C-FLIP promotes the motility of cancer cells by activating FAK and ERK, and increasing MMP-9 expression.
Park D; Shim E; Kim Y; Kim YM; Lee H; Choe J; Kang D; Lee YS; Jeoung D
Mol Cells; 2008 Apr; 25(2):184-95. PubMed ID: 18414015
[TBL] [Abstract][Full Text] [Related]
39. Adhesion and migration of polymorphonuclear leukocytes across human brain microvessel endothelial cells are differentially regulated by endothelial cell adhesion molecules and modulate monolayer permeability.
Wong D; Prameya R; Dorovini-Zis K
J Neuroimmunol; 2007 Mar; 184(1-2):136-48. PubMed ID: 17291598
[TBL] [Abstract][Full Text] [Related]
40. Integrin signaling and cell spreading alterations by rottlerin treatment of chick limb bud mesenchymal cells.
Choi YA; Kim DK; Kang SS; Sonn JK; Jin EJ
Biochimie; 2009 May; 91(5):624-31. PubMed ID: 19306958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]